VivoSeq
Other

Emergency Department Patient

0

Pipeline Programs

0

Active Trials

1

Companies Involved

Emergency Department Patient is an early-stage landscape with 0 programs across 1 company. The most active players are INSYS Therapeutics Inc.

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

75/100

Attrition Rate

25/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

12

clinical trials

Completed9 · 75%
Withdrawn2 · 17%
Terminated1 · 8%

Trial Activity

12 trials

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)